Source: Archives of Pathology & Laboratory Medicine. Unidades: FM, FMRP, FSP
Subjects: ANTÍGENOS, CARCINOMA, PULMÃO, NEOPLASIAS PULMONARES, LINFÓCITOS, IMUNOLOGIA, TAXA DE SOBREVIVÊNCIA
ABNT
PARRA, Edwin Roger et al. Variants in epithelial-mesenchymal transition and immune checkpoint genes are associated with immune cell profiles and predict survival in non–small cell lung cancer. Archives of Pathology & Laboratory Medicine, v. 144, n. 10, p. 1234-1244, 2020Tradução . . Disponível em: https://doi.org/10.5858/arpa.2019-0419-OA. Acesso em: 30 ago. 2024.APA
Parra, E. R., Jiang, M., Machado-rugolo, J., Yaegashi, L. B., Prieto, T., Farhat, C., et al. (2020). Variants in epithelial-mesenchymal transition and immune checkpoint genes are associated with immune cell profiles and predict survival in non–small cell lung cancer. Archives of Pathology & Laboratory Medicine, 144( 10), 1234-1244. doi:10.5858/arpa.2019-0419-OANLM
Parra ER, Jiang M, Machado-rugolo J, Yaegashi LB, Prieto T, Farhat C, Sá VK de, Nagai MA, Lima VCC de, Takagaki TY, Terra RM, Fabro AT, Capelozzi VL. Variants in epithelial-mesenchymal transition and immune checkpoint genes are associated with immune cell profiles and predict survival in non–small cell lung cancer [Internet]. Archives of Pathology & Laboratory Medicine. 2020 ; 144( 10): 1234-1244.[citado 2024 ago. 30 ] Available from: https://doi.org/10.5858/arpa.2019-0419-OAVancouver
Parra ER, Jiang M, Machado-rugolo J, Yaegashi LB, Prieto T, Farhat C, Sá VK de, Nagai MA, Lima VCC de, Takagaki TY, Terra RM, Fabro AT, Capelozzi VL. Variants in epithelial-mesenchymal transition and immune checkpoint genes are associated with immune cell profiles and predict survival in non–small cell lung cancer [Internet]. Archives of Pathology & Laboratory Medicine. 2020 ; 144( 10): 1234-1244.[citado 2024 ago. 30 ] Available from: https://doi.org/10.5858/arpa.2019-0419-OA